Table 5. Characteristics of pharmacogenetic tests that predict adverse drug reactions.
| Drug | Gene | Test | Performance characteristics | Reference |
|---|---|---|---|---|
| Abacavir | HLA-B*5701 | The HLA-B*5701 allele is associated with hypersensitivity reaction. Carriers should avoid abacavir. | Sensitivity: 100% Specificity: 96.9% PPV: 47.9% NPV: 100% | 37 |
| Carbamazepine | HLA-B*1502 | The HLA-B*1502 allele is associated with SJS-TEN in Han Chinese. Carriers should avoid carbamazepine. | Sensitivity: 98.3% Specificity: 97% PPV: 7.7% NPV: 100% | 38 |
| Purine analogues | TPMT | Impute 2 SNPs to identify patients with zero wildtype alleles, as they are at high risk of myelotoxicity. | Sensitivity: 100% Specificity: 99.0% PPV: 80.6% NPV: 100% | 39 |
Abbreviations: HLA, human leukocyte antigen; NPV, negative predictive value; PPV, positive predictive value; SNP, single nucleotide polymorphism.